Manulife Private Credit Plus Fund Files 424B3 Prospectus
| Field | Detail |
|---|---|
| Company | Manulife Private Credit Plus Fund |
| Form Type | 424B3 |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: prospectus, private-credit, fund-update
TL;DR
**Manulife Private Credit Plus Fund just updated its prospectus, giving investors fresh details on its private credit offering.**
AI Summary
Manulife Private Credit Plus Fund filed a 424B3 prospectus on March 24, 2026, detailing its offering. This filing, under CIK 0001988855, provides updated information about the fund's structure and operations, which is crucial for investors to understand how their money will be managed and the potential risks and returns associated with this specific private credit fund. For current or prospective shareholders, this means having the latest official information to evaluate their investment decision.
Why It Matters
This filing updates the official offering document, giving investors the most current details on the fund's investment strategy and terms.
Risk Assessment
Risk Level: medium — Private credit funds typically carry medium risk due to their illiquid nature and reliance on specific credit markets, as implied by a prospectus filing.
Analyst Insight
Investors should review the full 424B3 prospectus to understand any changes to the fund's investment strategy, fees, or risks before making investment decisions.
Key Numbers
- 424B3 — Form Type (Indicates a prospectus filing under Rule 424(b)(3), typically for a new or updated offering.)
- 0001193125-26-120956 — SEC Accession No. (Unique identifier for this specific filing on the SEC's EDGAR system.)
Key Players & Entities
- Manulife Private Credit Plus Fund (company) — the Filer of the 424B3 prospectus
- 0001988855 (company) — the CIK (Central Index Key) for Manulife Private Credit Plus Fund
- 2026-03-24 (date) — the filing date and acceptance date of the 424B3 prospectus
- 333-280481 (dollar_amount) — the File No. for the filing, indicating its registration statement
FAQ
What is the purpose of the 424B3 filing by Manulife Private Credit Plus Fund?
The 424B3 filing, submitted on March 24, 2026, is a prospectus (Rule 424(b)(3)) which provides updated or new information about the fund's offering to potential investors, as indicated by the document type '424B3' and the description 'MANULIFE PRIVATE CREDIT PLUS FUND d88541d424b3.htm'.
When was this specific 424B3 filing accepted by the SEC?
This 424B3 filing was accepted by the SEC on March 24, 2026, at 10:18:05, as stated in the 'Accepted' field of the filing detail.
Filing Stats: 316 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2026-03-24 10:18:05
Filing Documents
- d88541d424b3.htm (424B3) — 6KB
- g113159jhim_fcv.jpg (GRAPHIC) — 6KB
- 0001193125-26-120956.txt ( ) — 15KB
From the Filing
PRIVATE CREDIT PLUS FUND Manulife Private Credit Plus Fund Prospectus Supplement Manulife Private Credit Plus Fund (the fund) Supplement dated March 24, 2026 to the current Prospectus, as may be supplemented (the Prospectus) At its meeting held on March 23, 2026, the Board of Trustees (the "Board" or the "Trustees") of the fund, a closed-end fund operating as a tender offer fund, including, as applicable, a majority of the Trustees who are not "interested persons" of the fund, as defined under the Investment Company Act of 1940, as amended (the "1940 Act"), considered and approved: (1) the election of three (3) Trustees as members of the Board (the "Election"); and (2) other related changes. The Board's approval of the Election are subject to the approval of the fund's shareholders ("Shareholders"). Accordingly, at an upcoming special meeting of Shareholders to be held on June 18, 2026 (the "Shareholder Meeting"), including any adjournment or postponement thereof, Shareholders will be asked to approve the Election. Shareholders will not be asked to approve any other changes. More detailed information about the Election to be voted on at the Shareholder Meeting will be provided in a forthcoming proxy statement on or about May 7, 2026. When you receive your proxy statement, please review it carefully and cast your vote to avoid the additional expense to the fund of any future solicitations. This Supplement is not a proxy and is not soliciting any proxy, which can only be done by means of a proxy statement. You should read this supplement in conjunction with the Prospectus and retain it for your future reference. Manulife, Manulife Investments, Stylized M Design, and Manulife Investments & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and John Hancock, and the Stylized John Hancock Design are trademarks of John Hancock Life Insurance Company (U.S.A.). Each are used by it and by its affiliates under license.